Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Paolo Stobbione"'
Autor:
Maria C. Sacchi, Stefania Tamiazzo, Paolo Stobbione, Lisa Agatea, Piera De Gaspari, Anna Stecca, Ernesto C. Lauritano, Annalisa Roveta, Renato Tozzoli, Roberto Guaschino, Ramona Bonometti
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 3, Pp 898-907 (2021)
Abstract Currently, few evidences have shown the possible involvement of autoimmunity in patients affected by coronavirus disease 2019 (COVID‐19). In this study, we elucidate whether severe acute respiratory syndrome coronavirus disease 2 (SARS‐C
Externí odkaz:
https://doaj.org/article/5674f34b8ca748a5b34d45c5c1e3b0f3
Autor:
Ramona Bonometti, Anna Stecca, Stefania Tamiazzo, Annalisa Roveta, Piera De Gaspari, Lisa Agatea, Paolo Stobbione, Renato Tozzoli, Ernesto Cristiano Lauritano, Roberto Guaschino, Maria Cristina Sacchi
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 14, Iss 3, Pp 898-907 (2021)
Clinical and Translational Science, Vol 14, Iss 3, Pp 898-907 (2021)
Currently, few evidences have shown the possible involvement of autoimmunity in patients affected by coronavirus disease 2019 (COVID‐19). In this study, we elucidate whether severe acute respiratory syndrome coronavirus disease 2 (SARS‐CoV‐2) s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b53db69c00ecf17aa4f48c12bd093a6d
https://doi.org/10.1111/cts.12953
https://doi.org/10.1111/cts.12953
Autor:
Emanuele Nicastri, Paolo Stobbione, Fabrizio Cantini, Daniela Matarrese, Laura Niccoli, Delia Goletti
Publikováno v:
The Journal of Infection
Journal of Infection
Journal of Infection
Highlights • Baricitinib, an anti-JAK1/JAK2, reduces cytokine release and SARS-Co-V2 entry. • In a retrospective multicenter study baricitinib reduces COVID-19 mortality rate. • Baricitinib reduces intensive care unit admissions of COVID-19 pne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::052714f41bec6adb9879be3d4cf15e82
https://doi.org/10.1016/j.jinf.2020.04.017
https://doi.org/10.1016/j.jinf.2020.04.017
Autor:
Stefania Tamiazzo, Ramona Bonometti, Antonio Maconi, Maria Cristina Sacchi, Piera De Gaspari, Lisa Agatea, Enrico Cristiano Lauritano, Paolo Stobbione, Maria Matilde Ciriello
Publikováno v:
Archives of Clinical and Biomedical Research.
Background: Various factors, such as viral infections, can act as triggers for the development of autoimmune diseases.In our recent study we reported the presence of autoantibodies in patients diagnosed with COVID-19. To verify whether these autoanti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::366a5178dfd3e2ca0578def0f244bb42
https://doi.org/10.26502/acbr.50170220
https://doi.org/10.26502/acbr.50170220
Autor:
Fabrizio Cantini, Massimo Edoardo Di Natale, Paolo Stobbione, Assunta Navarra, Carlotta Nannini, Laura Niccoli, Gabriele Frausini, Giancarlo Landini, Massimo Di Pietro, Barbara Cimolato, Michele Trezzi, Pamela Lotti, Emanuele Nicastri, Giovanni Sotgiu, Daniela Matarrese, Delia Goletti, D. Aquilini
Publikováno v:
Journal of Infection
• Baricitinib, an anti-JAK1/JAK2, reduces cytokine release and SARS-Co-V2 entry. • In a retrospective multicenter study baricitinib reduces COVID-19 mortality rate. • Baricitinib reduces intensive care unit admissions of COVID-19 pneumonia. •
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9dfd1fc8485f5c70e5c689833552346
Autor:
Annalisa Roveta, Maria Cristina Sacchi, Paolo Stobbione, Ramona Bonometti, Stefania Tamiazzo, Ernesto Cristiano Lauritano, Roberto Guaschino
Publikováno v:
Working Paper of Public Health. 8
Objective: The study evaluated the autoimmune profile of COVID-19 positive hospitalised patients. Methods: 40 hospitalised patients with a confirmed diagnosis of COVID-19 were given clinical chemistry and autoimmunity tests. Results: The 40 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f8d4270233e1e761b924027a5c0d933
https://doi.org/10.4081/wpph.2020.9246
https://doi.org/10.4081/wpph.2020.9246
Autor:
Francesco Cianci, Francesco Ferro, Viviana Ravagnani, Sara Monti, Angela Padula, Silvia Balduzzi, Alvise Berti, Roberto Caporali, Paolo Stobbione, Marcello Govoni, Silvano Bettio, I. Leccese, M. C. Ditto, Stefano Murgia, Marco Matucci Cerinic, Lorenzo Dagna, Franco Schiavon, Federica Furini, Alessandra Bortoluzzi, Michele Colaci, Silvia Bellando Randone, Bernd Raffeiner, P.P. Sainaghi, Gian Luca Erre, Francesco Carubbi, Dario Roccatello, Milena Bond, Giulia Pazzola, Giuseppe Paolazzi, Mara Felicetti, Carlo Salvarani, Giuseppina Alfieri, Aurora Ianniello, Elena Silvestri, Roberto Padoan, Alessandro Giollo, Luca Quartuccio, Roberto Bortolotti, Claudia Lomater, Simone Parisi, Adriana Cariddi, Enrica Bozzolo, Salvatore D'Angelo, Giacomo Emmi, Salvatore De Vita, Gerardo Di Scala, Miriam Isola, Pietro Leccese, Elisa Gremese, Nicoletta Franzolini, Fabrizio Conti, Paola Faggioli
Introduction Alveolar haemorrhage (AH) is considered an important cause of morbidity and early mortality in anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitides (AAV). Objectives The aim of this study was to identify predictors of ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::424fe2935c43ddfcf00bd87e73899144
https://hdl.handle.net/11562/1082388
https://hdl.handle.net/11562/1082388
Autor:
Maria Manara, Roberto Caporali, Claudia Lomater, Roberto Gorla, Enrico Fusaro, Piercarlo Sarzi-Puttini, Paolo Stobbione, Stefano Capri, Luigi Sinigaglia
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
We aimed to evaluate the impact of biologic therapy on work productivity outcomes in an Italian real-life cohort of biologic-naïve patients with active rheumatoid arthritis (RA).This observational prospective multicentre study enrolled RA patients i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9673c02fae6ec498dca9b3eb0c9efa68
https://pubmed.ncbi.nlm.nih.gov/32573407
https://pubmed.ncbi.nlm.nih.gov/32573407
Autor:
Giuseppe Aiosa, Massimo Desperati, Paolo Stobbione, Gianmauro Numico, Marco Manganaro, Marco Ladetto, Piero Davio, Biagio Polla, Roberta Bellini, Riccardo Boverio, Giacomo Centini, Luigi Ruiz, Daniela Kozel, Carlo Gemme, Cristian Zanelli, Gianfranco Pistis, Aldo Bellora, Guido Chichino, Roberto Ippoliti
Publikováno v:
Internal and emergency medicine. 15(6)
Given the high hospital costs, the increasing clinical complexity and the overcrowding of emergency departments, it is crucial to improve the efficiency of medical admissions. We aimed at isolating organizational drivers potentially targetable throug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a4bf09a9ea759c5b6ee4d1196a2a30c
https://pubmed.ncbi.nlm.nih.gov/32253573
https://pubmed.ncbi.nlm.nih.gov/32253573